ÂÜÀòÂÒÂ×

Charlene Barroga, PhD, DABT, currently serves as Vice President of Non-Clinical Drug Safety at Enveda Biosciences, overseeing Non-Clinical Strategy and IND-enabling studies to ensure the development of safe and effective drugs. With a robust background in toxicology and drug development, Charlene was previously the President & CEO of Tessellux Consulting, where responsibilities included developing compliant IND-enabling strategies and conducting toxicity studies across various therapeutic areas. At Samumed, LLC, as Executive Director of Nonclinical Development, Charlene led the Pharmacology-Toxicology Division and managed multiple preclinical programs, particularly in oncology and neurodegeneration. Educationally, Charlene holds a PhD in Biochemistry and Molecular Biology from Purdue University and has achieved multiple certifications in pharmacology, toxicology, and regulatory affairs.